Concord Medical - Spon ADRCCM
13F holders, Q4 2024 (December 31)3holders +1
0new positions
0sold out
$5.38avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding Concord Medical - Spon ADR (CCM) in their 13F filings, up 1 from Q3 2024. 0 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($13K), UBS Group AG ($4K) and SBI Securities Co., Ltd. ($22).
- Company
- Concord Medical - Spon ADR
- CUSIP
- 206277204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 264 shares sold, net −264 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Rhumbline Advisers | 0.00% | No change | 2,460 | $13K |
| UBS Group AG | 0.00% | Reduce -28.6% | 659 | $4K |
| SBI Securities Co., Ltd. | 0.00% | — | 4 | $22 |
"% of holder's portfolio" is CCM's weight in each manager's 13F, not the share of Concord Medical - Spon ADR the manager owns.